RETRACTION: Chidamide Inhibits Glioma Cells by Increasing Oxidative Stress via the miRNA-338-5p Regulation of Hedgehog Signaling
- PMID: 40786144
- PMCID: PMC12334280
- DOI: 10.1155/omcl/9783207
RETRACTION: Chidamide Inhibits Glioma Cells by Increasing Oxidative Stress via the miRNA-338-5p Regulation of Hedgehog Signaling
Abstract
[This retracts the article DOI: 10.1155/2020/7126976.].
Copyright © 2025 Oxidative Medicine and Cellular Longevity published by John Wiley & Sons Ltd.
Retraction of
-
Chidamide Inhibits Glioma Cells by Increasing Oxidative Stress via the miRNA-338-5p Regulation of Hedgehog Signaling.Oxid Med Cell Longev. 2020 Mar 11;2020:7126976. doi: 10.1155/2020/7126976. eCollection 2020. Oxid Med Cell Longev. 2020. Retraction in: Oxid Med Cell Longev. 2025 Aug 1;2025:9783207. doi: 10.1155/omcl/9783207. PMID: 32256960 Free PMC article. Retracted.
Similar articles
-
Chidamide Inhibits Glioma Cells by Increasing Oxidative Stress via the miRNA-338-5p Regulation of Hedgehog Signaling.Oxid Med Cell Longev. 2020 Mar 11;2020:7126976. doi: 10.1155/2020/7126976. eCollection 2020. Oxid Med Cell Longev. 2020. Retraction in: Oxid Med Cell Longev. 2025 Aug 1;2025:9783207. doi: 10.1155/omcl/9783207. PMID: 32256960 Free PMC article. Retracted.
-
Expression of Concern.Eur Rev Med Pharmacol Sci. 2025 Jun;29(6):287-288. doi: 10.26355/eurrev_202506_37270. Eur Rev Med Pharmacol Sci. 2025. PMID: 40613620
-
Glioma-Associated Mesenchymal Stromal/Stem Cells Derived Exosomal miR-191 Promotes the Proneural-to-Mesenchymal Transition in Glioblastoma Cells via PTEN/PI3K/AKT Signaling.Int J Nanomedicine. 2025 Jul 7;20:8811-8831. doi: 10.2147/IJN.S515771. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40657483 Free PMC article.
-
Deciphering the miRNA-mRNA Interaction Network Regulating Aging Skeletal Muscle in Various Exercise Regimens through Comprehensive Bioinformatics Analysis.Cell Biochem Biophys. 2025 Aug 1. doi: 10.1007/s12013-025-01848-6. Online ahead of print. Cell Biochem Biophys. 2025. PMID: 40748585 Review.
-
The role of chidamide in the treatment of B-cell non-Hodgkin lymphoma: An updated systematic review.Biomol Biomed. 2023 Sep 4;23(5):727-739. doi: 10.17305/bb.2023.8791. Biomol Biomed. 2023. PMID: 37004241 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources